REGENXBIO Inc. (RGNX)

REGENXBIO Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	530	790	982	1,399	1,697	1,511
Market Cap Growth	13.89%	-19.58%	-29.79%	-17.58%	12.32%	0.48%
Enterprise Value	276	602	710	1,026	1,292	1,224
PE Ratio	-	-3.00	-3.50	10.94	-15.25	-15.95
PS Ratio	6.11	8.75	8.71	2.97	10.98	42.88
PB Ratio	1.36	2.53	1.90	1.83	4.49	3.36
P/FCF Ratio	-4.71	-3.46	-4.12	10.38	-20.97	-12.65
P/OCF Ratio	-4.85	-3.62	-4.73	6.39	-31.39	-14.03
EV/Sales Ratio	3.18	6.67	6.30	2.18	8.36	34.75
EV/EBITDA Ratio	-2.88	-2.51	-2.91	5.79	-13.35	-13.55
EV/EBIT Ratio	-2.69	-2.34	-2.76	6.12	-12.28	-12.56
EV/FCF Ratio	-3.44	-2.63	-2.98	7.62	-15.97	-10.25
Debt / Equity Ratio	0.22	0.29	0.18	0.11	0.19	0.03
Debt / EBITDA Ratio	-0.37	-0.37	-0.39	0.49	-0.75	-0.13
Debt / FCF Ratio	-0.44	-0.39	-0.40	0.64	-0.90	-0.09
Quick Ratio	3.24	2.32	3.04	3.79	6.43	10.09
Current Ratio	3.59	2.57	3.19	3.98	6.52	10.25
Asset Turnover	0.14	0.14	0.12	0.52	0.29	0.07
Interest Coverage	-41.81	-37.42	-11.06	6.38	-136.50	-
Return on Equity (ROE)	-70.70%	-68.20%	-46.70%	22.40%	-27.60%	-19.90%
Return on Assets (ROA)	-41.30%	-40.00%	-30.30%	14.10%	-20.60%	-18.40%
Return on Capital (ROIC)	-55.62%	-66.86%	-43.02%	17.02%	-26.47%	-32.29%
Earnings Yield	-49.13%	-33.37%	-28.55%	9.14%	-6.56%	-6.27%
FCF Yield	-37.52%	-28.92%	-24.26%	9.63%	-4.77%	-7.91%
Buyback Yield / Dilution	-5.25%	-1.35%	1.73%	-17.79%	-1.61%	-0.11%
Total Shareholder Return	-5.25%	-1.35%	1.73%	-17.79%	-1.61%	-0.11%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).